Nadav Ahituv

Nadav Ahituv
Name	Nadav Ahituv
Nationality	Israeli
Fields	Human genetics, Genomics, Bioinformatics
Workplaces	University of California, San Francisco; Hebrew University of Jerusalem; Stanford University
Alma mater	Hebrew University of Jerusalem; Stanford University
Known for	Functional genomics of regulatory DNA, human genetic variation

Nadav Ahituv is an Israeli-born geneticist and molecular biologist noted for work on human regulatory DNA, non-coding variation, and functional genomics. He has held faculty positions at research institutions including the University of California, San Francisco, and his work connects experimental assays with clinical genetics, population genomics, and computational biology. Ahituv's research intersects with projects and organizations such as the ENCODE Project, the 1000 Genomes Project, and the National Institutes of Health funding mechanisms.

Early life and education

Ahituv received his early scientific training in Israel, attending the Hebrew University of Jerusalem where he studied molecular biology and genetics, and later pursued graduate work and postdoctoral research in the United States at institutions including Stanford University and laboratories connected with Harvard Medical School and the University of California, San Francisco. During his formative years he interacted with researchers associated with the Wellcome Trust Sanger Institute, the Broad Institute, and groups contributing to the Genome Project-Write discussions. His mentors and collaborators have included scientists linked to the Howard Hughes Medical Institute and to centers such as the Gladstone Institutes and the Children's Hospital Oakland Research Institute.

Research and career

Ahituv established a laboratory that integrates experimental regulatory assays, high-throughput reporter screens, and computational annotation pipelines to study cis-regulatory elements and enhancers in humans and model organisms. His lab has collaborated with teams at the ENCODE Project, the Roadmap Epigenomics Project, and the Genotype-Tissue Expression (GTEx) Project to map regulatory architecture across tissues, working alongside investigators from the Wellcome Trust-funded consortia, the European Molecular Biology Laboratory (EMBL), and the National Human Genome Research Institute (NHGRI). He has published with colleagues from the Broad Institute, MIT, Harvard University, Yale University, Columbia University, University of Cambridge, University of Oxford, Max Planck Institute, and the Salk Institute on topics ranging from enhancer function to the interpretation of rare variants.

Methodologically, Ahituv's group employs massively parallel reporter assays (MPRAs), CRISPR-based perturbations, and comparative genomics approaches developed in collaboration with groups at Stanford University, University of California, Berkeley, and the McGill University community. His career has involved translational linkages to clinical genetics centers including Mayo Clinic, Cleveland Clinic, and Children's Hospital Boston, and participation in initiatives funded by agencies such as the Israel Science Foundation and the European Research Council.

Key contributions and discoveries

Ahituv made significant contributions to the experimental dissection of enhancers, demonstrating how non-coding variants can alter gene expression and contribute to human traits and diseases. His publications have clarified the functional consequences of sequence changes discovered in cohorts from the 1000 Genomes Project, Exome Aggregation Consortium (ExAC), and the Genome Aggregation Database (gnomAD), and have provided frameworks used by clinical consortia like the American College of Medical Genetics and Genomics for variant interpretation. He has helped map regulatory elements relevant to developmental disorders studied with investigators at the Institute of Molecular Biology (IMB), St. Jude Children's Research Hospital, and the Max Delbrück Center for Molecular Medicine.

Notable discoveries include experimental catalogs of tissue-specific enhancers connected to genes implicated in neurodevelopmental phenotypes studied by groups at Cold Spring Harbor Laboratory, the Scripps Research Institute, and the Johns Hopkins University School of Medicine, as well as reports on the mechanisms by which distal regulatory elements control gene expression during limb and craniofacial development, with collaborative links to the Karolinska Institutet and the University of Copenhagen. His work has informed studies of evolutionary conservation and human-specific regulatory changes researched at the Howard Hughes Medical Institute and the Royal Society-affiliated laboratories.

Awards and recognition

Ahituv has been recognized by funding agencies and professional societies for contributions to genomics and genetics, receiving grants and honors in competition with investigators from institutions such as NIH, the Wellcome Trust, and the European Research Council. His publications have been cited across literature involving teams from Massachusetts General Hospital, UCL, Imperial College London, and the Babraham Institute. He has lectured at international meetings including conferences organized by the American Society of Human Genetics, the International Congress of Genetics, and the Cold Spring Harbor Laboratory meetings, and has served on panels alongside representatives from the National Academy of Sciences and the Royal Society.

Personal life and impact on science policy

Outside the laboratory, Ahituv has engaged with science policy discussions concerning genomic medicine implementation, variant curation, and data sharing, participating in workshops with stakeholders from the World Health Organization, the European Commission, and national agencies such as the Israeli Ministry of Health. He has been involved in efforts to translate regulatory genomics into clinical practice, collaborating with policy groups linked to the Global Alliance for Genomics and Health and contributing to recommendations used by clinical laboratories affiliated with ClinGen and large healthcare systems like Kaiser Permanente. Colleagues from academic and translational centers including UCSF Benioff Children's Hospitals, Stanford Medicine, and Mount Sinai Health System have cited his influence on protocols for non-coding variant interpretation.

Category:Israeli geneticists Category:Human geneticists